Find us on social media:
Twitter: AMARI Consortium
Facebook: AMARI Consortium
Linkedin: AMARI Consortium
YouTube: AMARI Consortium
About AMARI-II
The African Mental Health Research Initiative (AMARI) is a mental health research capacity building programme launched in 2015 to build an Africa-led network of future leaders in mental, neurological and substance use (MNS) research in Africa. AMARI is implementing its second phase, AMARI-II (2023-2027) with funding support from the second phase of the Developing Excellence in Leadership, Training, and Science in Africa (DELTAS Africa), a programme of the Science for Africa Foundation (SFA) being implemented with support from Wellcome and the UK Foreign, Commonwealth & Development Office (FCDO).
AMARI-II is a consortium of six African universities namely; Addis Ababa University, Kamuzu University of Health Sciences, University of Cape Town, University of Ghana, University of Zambia and University of Zimbabwe. These are supported by two UK universities namely; King’s College London and London School of Hygiene & Tropical Medicine. AMARI-II’s overall goal is to build excellence in leadership, training, and science amongst African scholars in MNS research in Africa.
AMARI-II aims to shift the centre of gravity in global mental health (GMH) by ensuring that African scientists become leaders in GMH research, training and implementation. A particular focus is on AMARI-II’s collective ability to introduce interventions that reduce the treatment gap for mental health disorders in Africa.
Areas of Research
HIV & AIDS
Assessing for neuro-cognitive disorders associated with HIV. Improving sex-workers' adherence to HIV antiretroviral medication.
overcoming addiction
Experiences of recovery from substance misuse through finding new roles in life. Intervention in emergency room settings for alcohol and drug misuse.
maternal & child health
Impact of maternal depression on mother-to-child HIV transmission. Psycho-social interventions to treat peri-natal depression.
mental health in physical disease
Validating screening tools for depression in non-communicable diseases like diabetes. Assessing interactions of psychiatric and physical medications.
serious mental illness
Trans-generational impact of Serious Mental Illness in families, and the economic costs of SMI. Psycho-social interventions for Bipolar Disorder in primary care. Understanding cognitive impairment in psychosis.
caregiver burden
Understanding the challenges faced by those who care for people with serious medical conditions.